A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA)

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Pedersen, Kristina ^a,b,c   Wiechec, Emilia ^a,b   Madsen, Bo E ^a,d   Overgaard, Jens ^b   Hansen, Lise Lotte ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MARYLAND   (United States)

^d Institute for Agri Technology and Food Innovation   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955349659     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-179     Document Type: Article

References (15)

1. Global variation in copy number in the human genome. R Redon S Ishikawa KR Fitch L Feuk GH Perry TD Andrews H Fiegler MH Shapero AR Carson W Chen, et al. Nature 2006 444 7118 444 454 10.1038/nature05329 17122850
2. Multiplex ligation-dependent probe amplification using a completely synthetic probe set. RF Stern RG Roberts K Mann SC Yau J Berg CM Ogilvie, Biotechniques 2004 37 3 399 405 15470894
3. Novel, ligation-dependent PCR assay for detection of hepatitis C in serum. TC Hsuih YN Park C Zaretsky F Wu S Tyagi FR Kramer R Sperling DY Zhang, J Clin Microbiol 1996 34 3 501 507 8904402
4. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. JP Schouten CJ McElgunn R Waaijer D Zwijnenburg F Diepvens G Pals, Nucleic Acids Res 2002 30 12 e57 10.1093/nar/gnf056 12060695
5. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. SK Murthy AO Nygren HM El Shakankiry JP Schouten AI Al Khayat A Ridha MT Al Ali, Cytogenet Genome Res 2007 116 1-2 135 140 10.1159/000097433 17268193
6. DNA copy number changes at 8q11-24 in metastasized colorectal cancer. TE Buffart J Coffa MA Hermsen B Carvalho JR van der Sijp B Ylstra G Pals JP Schouten GA Meijer, Cell Oncol 2005 27 1 57 65 15750208
7. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. AO Nygren N Ameziane HM Duarte RN Vijzelaar Q Waisfisz CJ Hess JP Schouten A Errami, Nucleic Acids Res 2005 33 14 128 10.1093/nar/gni127 16106041
8. Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. E Eldering CA Spek HL Aberson A Grummels IA Derks AF de Vos CJ McElgunn JP Schouten, Nucleic Acids Res 2003 31 23 153 10.1093/nar/gng153 14627843
9. Gene dosage imbalances in patients with 46,XY gonadal DSD detected by an in-house-designed synthetic probe set for multiplex ligation-dependent probe amplification analysis. M Barbaro A Cicognani A Balsamo A Lofgren L Baldazzi A Wedell M Oscarson, Clin Genet 2008 73 5 453 464 10.1111/j.1399-0004.2008.00980.x 18384427
10. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. K Wu A Li M Rao M Liu V Dailey Y Yang D Di Vizio C Wang MP Lisanti G Sauter, et al. Mol Cell Biol 2006 26 19 7116 7129 10.1128/MCB.00268-06 16980615
11. The new tumor suppressor genes ING: genomic structure and status in cancer. D Ythier D Larrieu C Brambilla E Brambilla R Pedeux, Int J Cancer 2008 123 7 1483 1490 10.1002/ijc.23790 18636562
12. A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells. DR Croucher DN Saunders GE Stillfried M Ranson, Biochem J 2007 408 2 203 210 10.1042/BJ20070767 17696882
13. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. LL Hansen M Yilmaz J Overgaard J Andersen TA Kruse, Cancer Res 1998 58 10 2166 2169 9605761
14. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement. LL Hansen J Andersen J Overgaard TA Kruse, Apmis 1998 106 3 371 377 10.1111/j.1699-0463. 1998.tb01359.x 9548425
15. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes. M Wehner E Mangold M Sengteller N Friedrichs S Aretz W Friedl P Propping C Pagenstecher, Eur J Hum Genet 2005 13 8 983 986 10.1038/sj.ejhg.5201421 15870828